Rhumbline Advisers Quanterix Corp Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

A detailed history of Rhumbline Advisers transactions in Quanterix Corp stock. As of the latest transaction made, Rhumbline Advisers holds 60,444 shares of QTRX stock, worth $797,860. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,444

Previous 67,556 10.53%

Holding current value

$797,860

Previous $1.59 Million 49.84%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$12.26 - $23.78 $87,193 - $169,123	-7,112 Reduced 10.53%	60,444 $798,000
Q1 2024 May 09, 2024	SELL	$21.9 - $28.28 $22,819 - $29,467	-1,042 Reduced 1.52%	67,556 $1.59 Million
Q4 2023 Feb 08, 2024	BUY	$19.54 - $28.66 $37,888 - $55,571	1,939 Added 2.91%	68,598 $1.88 Million
Q3 2023 Nov 09, 2023	BUY	$21.15 - $27.96 $59,706 - $78,931	2,823 Added 4.42%	66,659 $1.81 Million
Q2 2023 Aug 08, 2023	SELL	$11.16 - $23.65 $29,462 - $62,435	-2,640 Reduced 3.97%	63,836 $1.44 Million
Q1 2023 May 11, 2023	BUY	$10.12 - $14.91 $38,324 - $56,464	3,787 Added 6.04%	66,476 $749,000
Q4 2022 Feb 14, 2023	BUY	$8.75 - $14.02 $101,500 - $162,632	11,600 Added 22.71%	62,689 $868,000
Q3 2022 Nov 10, 2022	BUY	$7.46 - $19.28 $19,515 - $50,436	2,616 Added 5.4%	51,089 $563,000
Q2 2022 Aug 11, 2022	BUY	$15.06 - $30.65 $229,966 - $468,025	15,270 Added 45.99%	48,473 $785,000
Q1 2022 May 12, 2022	BUY	$23.26 - $42.41 $19,445 - $35,454	836 Added 2.58%	33,203 $969,000
Q4 2021 Feb 10, 2022	SELL	$37.54 - $57.51 $16,555 - $25,361	-441 Reduced 1.34%	32,367 $1.37 Million
Q3 2021 Nov 12, 2021	BUY	$45.91 - $59.67 $61,335 - $79,719	1,336 Added 4.25%	32,808 $1.63 Million
Q2 2021 Aug 05, 2021	BUY	$43.3 - $67.17 $247,199 - $383,473	5,709 Added 22.16%	31,472 $1.85 Million
Q1 2021 May 06, 2021	BUY	$44.11 - $90.64 $32,067 - $65,895	727 Added 2.9%	25,763 $1.51 Million
Q4 2020 Feb 10, 2021	BUY	$33.89 - $49.88 $78,285 - $115,222	2,310 Added 10.16%	25,036 $1.16 Million
Q3 2020 Nov 12, 2020	SELL	$26.91 - $37.47 $24,434 - $34,022	-908 Reduced 3.84%	22,726 $767,000
Q2 2020 Aug 13, 2020	BUY	$19.21 - $28.53 $173,447 - $257,597	9,029 Added 61.82%	23,634 $647,000
Q1 2020 May 06, 2020	BUY	$11.17 - $28.72 $10,343 - $26,594	926 Added 6.77%	14,605 $268,000
Q4 2019 Feb 05, 2020	BUY	$19.29 - $25.52 $18,479 - $24,448	958 Added 7.53%	13,679 $323,000
Q3 2019 Oct 23, 2019	BUY	$21.72 - $35.38 $31,906 - $51,973	1,469 Added 13.06%	12,721 $279,000
Q2 2019 Aug 14, 2019	BUY	$20.59 - $35.2 $28,990 - $49,561	1,408 Added 14.3%	11,252 $380,000
Q1 2019 May 01, 2019	SELL	$17.28 - $25.83 $5,304 - $7,929	-307 Reduced 3.02%	9,844 $254,000
Q4 2018 Jan 31, 2019	BUY	$16.17 - $20.8 $164,141 - $211,140	10,151 New	10,151 $186,000

Others Institutions Holding QTRX

# of Institutions

158

Shares Held

32.1M

Call Options Held

39K

Put Options Held

5.5K

View Full List

About Quanterix Corp

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $488M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

More about QTRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Quanterix Corp Transaction History